North America AREDS 2 Supplements Market Growth & Trends
The North America AREDS 2 supplements market size is expected to reach USD 423.1 million by 2030, registering a CAGR of 6.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The North America AREDS 2 supplements market is experiencing significant growth, driven by a combination of health trends, demographic shifts, and technological advancements. At the forefront of this growth is the increasing prevalence of chronic eye diseases, particularly Age-related Macular Degeneration (AMD). The AREDS 2 formula, which includes specific dosages of zinc, lutein, zeaxanthin, and various vitamins, has shown promising results in reducing the risk of disease progression and preserving functional vision, making it a go-to choice for those at risk or already affected by AMD.
Awareness about eye health and the benefits of supplements like AREDS 2 has grown substantially in recent years. This increased awareness, coupled with the widespread availability of these supplements over-the-counter and through various sales channels, including online platforms, has significantly boosted market growth. The COVID-19 pandemic has further accelerated this trend, with a notable increase in internet sales of eye health supplements. This shift in consumer behavior has made these products more accessible to a broader audience, contributing to the market’s expansion.
Product innovation and new launches are playing a crucial role in driving the market forward. Companies in the sector are continuously developing new formulations to meet evolving consumer needs. For instance, in May 2024, EyePromise, a leading nutraceutical company specializing in eye health, unveiled the latest enhancements to its extensive nutritional program tailored for eyecare practices. Focused on innovation and enhancement, EyePromise has enhanced its AREDS 2-based products. These scientifically backed formulas will now be branded as Macular Health and Macular Health Complete.
Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report
North America AREDS 2 Supplements Market Report Highlights
- North America AREDS 2 soft gels market accounted for a share of over 49% of the North Americas revenues in 2023. This innovative two-in-one soft gel addresses the needs of the aging population who are managing both age-related macular degeneration (AMD) and heart disease, offering a convenient solution that simplifies their supplement regimen. Leading companies are enhancing their product offerings with soft gels, which are favored for their ease of swallowing, precise dosage, and better absorption
- The sales of North America AREDS 2 supplements through online distribution channels are projected to grow at a CAGR of 6.9% from 2024 to 2030. AREDS 2 supplements offered by most companies are available through Amazon, providing an online shopping option for those who prefer digital convenience. Companies prefer a multi-channel approach to enhance product availability and meet the diverse purchasing preferences of North American consumers. The COVID-19 pandemic further accelerated the shift towards online shopping as consumers prioritize health and safety
- The AREDS 2 supplements market in the U.S. is projected to grow at a CAGR of 6.3% from 2024 to 2030. The market for AREDS 2 supplements in the U.S. is primarily driven by the growing awareness of age-related macular degeneration (AMD) and the desire for preventative measures among the aging population. AMD is a leading cause of vision loss among older adults, making it a significant public health concern
North America AREDS 2 Supplements Market Segmentation
Grand View Research has segmented the North America AREDS 2 supplements market on the basis of product, distribution channel, and country.
North America AREDS 2 Supplements Product Outlook (Revenue, USD Million, 2018 – 2030)
- Capsules
- Tablets
- Soft gels
- Others
North America AREDS 2 Supplements Distribution Channel Outlook (Revenue, USD Million, 2018 – 2030)
- Pharmacies
- Online
- Others
North America AREDS 2 Supplements Country Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- U.S.
- Canada
- Mexico
List of Key Players in the North America AREDS 2 Supplements Market
- Bausch + Lomb
- Alcon Inc.
- Nature Made (Pharmavite LLC)
- EyePromise (ZeaVision, LLC)
- MacuHealth
- Viteyes (Vitamin Health, Inc.)
- Codeage LLC
- NATURELO Premium Supplements, LLC
- NutraChamps Inc.
- VISTA
Browse Full Report: https://www.grandviewresearch.com/industry-analysis/north-america-areds-2-supplements-market-report